Viewing Study NCT05585567


Ignite Creation Date: 2025-12-25 @ 12:27 AM
Ignite Modification Date: 2026-01-05 @ 6:15 PM
Study NCT ID: NCT05585567
Status: UNKNOWN
Last Update Posted: 2022-11-07
First Post: 2022-10-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Preliminary Exploratory Study to Evaluate the Safety and Immunogenicity of Omicron Variant Bivalent Vaccine V-01-B5
Sponsor: Livzon Pharmaceutical Group Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None COVID-19 Pandemic View
Keywords: